Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sviatoslav Chekhun"'
Autor:
Sviatoslav Chekhun, Assumpció Lopez-Paradís, Aintzane Urbizu, Teresa Morán, Anabel Mañes, Marc Cucurull, Carlos Martínez-Barenys, Iris Teruel, Gloria Moragas, Enric Carcereny, Ana Maria Muñoz Mármol, Maria Saigí
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 4, Iss 6, Pp 1182-1187 (2023)
Third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have shown impressive results in EGFR mutant lung cancer (LC) patients in terms of disease control rate with a positive impact on overall survival. Nevertheles
Externí odkaz:
https://doaj.org/article/548b16587d6e4b5780c5798654aef425
Autor:
Christian Andre Mariño Siancas, Ainhoa Hernandez Gonzalez, Marta Domenech, Anna Esteve-Codina, Oriol Arpi, Francesc Alameda, Estela Pineda, Sviatoslav Chekhun, Assumpcio Lopez Paradis, Sonia Del Barco, Nuria de la Iglesia, Oscar Gallego Rubio, Carlos Mesia, Mar Mallo, Anna Esteve, Cristina Carrato, Carmen Balana, María Martínez-García
Publikováno v:
Journal of Clinical Oncology. 40:e14039-e14039
e14039 Background: Glioblastoma (GB) is the most prevalent primary brain tumor in adults. The first-line treatment is based on standard brain surgery and adjuvant radio-chemotherapy. Indoleamine 2,3-dioxygenase 1 (IDO1) is a catabolic enzyme that pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1842d12a8e3947f788c276ed611a8298
https://doi.org/10.1200/jco.2022.40.16_suppl.e14039
https://doi.org/10.1200/jco.2022.40.16_suppl.e14039
Publikováno v:
Clinical Oncology Week; 1/1/2024, p162-162, 1p